Financials
- Market Capitalization 9.79 B
- Employee 228
- Founded 2017
- CEO N/A
- Website www.nuvalent.com
- Headquarter Delaware, United States
- FIGI BBG00Z1SLMK5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-17.19
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 893 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 72.70 USD | -1.90% | -13.62% | -2.48% | +85.93% | 10.24 B USD | ||
| 906 | CYTK Cytokinetics, Incorporated - Common Stock | 81.51 USD | -0.89% | -5.64% | +16.19% | +40.29% | 10.14 B USD | ||
| 948 | IONS Ionis Pharmaceuticals, Inc. - Common Stock | 55.23 USD | -2.68% | -33.99% | -24.85% | -23.42% | 9.13 B USD | ||
| 959 | CORT Corcept Therapeutics Incorporated - Common Stock | 85.98 USD | +0.09% | -7.51% | +3.70% | +17.19% | 9.23 B USD |